Author:
Lee Sunyoung S.,Dy Grace K.
Reference180 articles.
1. Surveillance, Epidemiology, and End Results (SEER) 18 Registries;National Cancer Institute,2016
2. PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced non-squamous non-small-cell lung cancer;Senan;J Clin Oncol,2016
3. Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial;Wakelee;Lancet Oncol,2017
4. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial;Thatcher;Lancet Oncol,2015
5. EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma;He;Clin Cancer Res,2012